RESULTS FROM A PHASE I/II TRIAL OF TINOSTAMUSTINE MONOTHERAPY IN ADVANCED SOLID TUMOURS (NCT03345485): SAFETY AND EFFICACY IN A SUBSET OF PATIENTS WITH ADVANCED OVARIAN CANCER (OVCA)

被引：0
|
作者：
Tinker, Anna V. [1 ]
Chugh, Rashmi [2 ]
Curigliano, Giuseppe [3 ]
Kummar, Shivaani [4 ]
Schneider, Reva [5 ]
Strauss, James [5 ]
Janik, Tomas [6 ]
Manamley, Nick [6 ]
Hilgier, Kasia [6 ]
Oaknin, Ana [7 ]
机构：
[1] BC Canc, Vancouver, BC, Canada
[2] Univ Michigan, Rogel Comprehens Canc Ctr, Ann Arbor, MI USA
[3] European Inst Oncol, IRCCS, Milan, Italy
[4] Oregon Hlth & Sci Univ, Portland, OR USA
[5] Mary Crowley Canc Res, Dallas, TX USA
[6] Mundipharma Res Ltd, Cambridge, England
[7] Hosp Univ Vall Hebron, Gynaecol Canc Programme, Vall Hebron Inst Oncol VHIO, Vall Hebron Barcelona Hosp Campus, Barcelona, Spain
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2023年 / 33卷
关键词：
D O I：
10.1136/ijgc-2023-ESGO.526
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
163
引用
收藏
页码：A252 / A252
页数：1
相关论文
共 50 条
  • [31] Phase I trial of oral Deforolimus in combination with Bevacizumab in patients with advanced solid tumours
    Nemunaitis, J.
    Hochster, H. S.
    Lustgarten, S.
    Turner, C. D.
    Haluska, F.
    Mita, M. M.
    EJC SUPPLEMENTS, 2009, 7 (02): : 137 - 137
  • [32] Preliminary safety and efficacy of tinengotinib tablets as monotherapy and combination therapy in advanced solid tumors: A phase Ib/II clinical trial
    Piha-Paul, Sarina A.
    Goel, Sanjay
    Liao, Chih-Yi
    Gabrail, Nashat Y.
    Dayyani, Farshid
    Kazmi, Syed Mohammad Ali
    Yuan, Yuan
    Lavasani, Sayeh Moazami
    Fan, Jean
    Peng, Peng
    Sun, Caixia
    Wang, Hui
    Hennessy, Katie
    Fu, Ximei
    Ni, Shumao
    Tan, Hui Xian
    Ngo, Brenda
    Ru, Qinhua Cindy
    Wu, Frank
    Javle, Milind M.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [33] Results from the Cohort-Expansion Stage of a Phase I Trial of Tinostamustine Monotherapy in Advanced Hodgkin Lymphoma (HL), Non-Hodgkin Lymphoma (NHL) and Multiple Myeloma (MM) (NCT02576496)
    Sureda, Anna Maria
    Ghesquieres, Herve
    Morschhauser, Franck
    Mutsaers, Pim
    Ocio, Enrique M.
    Janik, Tomas
    Manamley, Nick
    Hilgier, Kasia
    Zinzani, Pier Luigi
    BLOOD, 2023, 142
  • [34] Safety and efficacy of sorafenib in patients with advanced thyroid carcinoma: a phase II study (NCT02084732)
    Fierro-Maya, Luis Felipe
    Gonzalez, Gloria Garavito
    Melo, Leonardo Javier Rojas
    Cuellar, Andres Arturo Cuellar
    Carreno, Alexander
    Cordoba, Claudia
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2021, 65 (04): : 404 - 410
  • [35] Phase I clinical trial of KML001 monotherapy in patients with advanced solid tumors
    Kim, Seokuee
    Kim, Sujong
    Park, Young Suk
    Park, Joon Oh
    Lim, Ho Yeong
    Ahn, Jin Seok
    Lee, Jeeyun
    Sun, Jong Mu
    Kang, Won Ki
    Han, RaeO
    Kim, Jungryul
    Ahn, Myung-Ju
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (09) : 1059 - 1067
  • [36] A phase I/II MATINS trial: Part 1 pharmacokinetic, safety and efficacy results of Clever-1 blockade in advanced cancer
    Bono, P.
    Jaakkola, P.
    Shetty, S.
    Ma, Y. T.
    de Jonge, M. J. A.
    Robbrecht, D.
    Minchom, A. R.
    Pal, A.
    Yap, C.
    Pasanen, A.
    Skytta, T.
    Thibault, A.
    Cruz, R.
    Jalkanen, M.
    Jalkanen, S.
    Hollmen, M.
    Mandelin, J.
    Karvonen, M.
    Koivunen, J.
    ANNALS OF ONCOLOGY, 2020, 31 : S706 - S707
  • [37] Lexatumumab: Results of phase I trial in pediatric patients with advanced solid tumors
    Merchant, M. S.
    Chou, A. J.
    Price, A.
    Geller, J. I.
    Tsokos, M.
    Graham, C.
    Charles, A.
    Meyers, P. A.
    Mackall, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [38] Safety and preliminary efficacy of MIL93 in patients with advanced solid tumors: The monotherapy part of a phase 1 trial.
    Huang, Jing
    Zhang, Bo
    Wang, Ying
    Wang, Feng
    Yu, Zhuang
    Wu, Shikai
    Zheng, Yi
    Cao, Yu
    Xu, Jianping
    Lan, Dongmei
    Wei, Min
    Liu, Sijun
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 798 - 798
  • [39] Efficacy and safety of sintilimab (anti-PD-1 mAb) for advanced cervical cancer: Results from a Phase II trial
    Gao, Qinglei
    Wang, Jing
    Xu, Qin
    Tang, Ying
    Zhang, Jieqing
    Chang, Baoping
    Xia, Bairong
    Duan, Wei
    Wang, Danbo
    Zhu, Lijing
    An, Ruifang
    Zhang, Guonan
    Tang, Yaling
    Huang, Jianli
    Zhang, Xiang
    Qiu, Hui
    Ji, Wenting
    Li, Li
    Zhu, Jianqing
    Ma, Ding
    CANCER RESEARCH, 2023, 83 (08)
  • [40] Ixabepilone given weekly in patients with advanced malignancies: Final efficacy and safety results of a phase I trial.
    Dickson, N.
    Peck, R.
    Wu, C.
    Burris, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 89S - 89S
12345